Acadia Pharmaceuticals buy Royal Bank of Canada
Start price
14.07.23
/
50%
€29.00
Target price
14.07.24
€29.37
Performance (%)
-44.09%
End price
15.07.24
€16.22
Summary
This prediction ended on 15.07.24 with a price of €16.22. The BUY prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals performed very badly with a performance of -44.09%. Royal_Bank_of_Canada has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -19.483% | -19.483% | -43.176% |
| iShares Core DAX® | -5.630% | -5.765% | 8.425% |
| iShares Nasdaq 100 | -8.559% | -13.005% | 17.297% |
| iShares Nikkei 225® | -9.576% | -9.058% | 3.827% |
| iShares S&P 500 | -6.631% | -7.103% | 17.407% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Royal Bank of Canada from $28.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.60
03.11.23
03.11.23
€30.73
03.11.24
03.11.24
-38.65%
07.08.24
07.08.24
Stopped prediction by Royal_Bank_of_Canada for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€13.87
07.08.24
07.08.24
€23.79
07.08.25
07.08.25
0.00%
07.08.24
07.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.79
25.06.24
25.06.24
€27.09
25.06.25
25.06.25
-6.25%
07.08.24
07.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.00
28.02.24
28.02.24
€32.29
28.02.25
28.02.25
-36.98%
07.08.24
07.08.24